The cervical cancer screening programme (HPV DNA Test) is a subsidy initiative under Budget 2025 provided by LPPKN.
It is given to eligible women for early detection using HPV DNA testing to prevent cervical cancer.
HPV DNA test (cervical cancer screening):
- Target: women aged 30–65
- Uses high-risk HPV DNA detection (more accurate than Pap smear) via self-sampling
- Free at Klinik Nur Sejahtera and through outreach programmes
- Results help detect cervical cancer risk before cell changes occur